Preparation and characterisation of andrographolide niosomes and its anti-hepatocellular carcinoma activity

References

• Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM, Leung BP, Wong WS. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med, 2009;179:657–65
   PubMed Web of Science ®Google Scholar
• Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res, 2000;14:333–8
   PubMed Web of Science ®Google Scholar
• Cheung HY, Cheung SH, Li J, Cheung CS, Lai WP, Fong WF, Leung FM. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med, 2005;71:1106–11
   PubMed Web of Science ®Google Scholar
• China SPCO. 2012. Chinese pharmacopoeia. Beijing: Chinese Medical Science and Technology Press
   Google Scholar
• Committee CP. 2010. Pharmacopeia of People's Republic of China. Beijing: China Press of Traditional Chinese Medicine
   Google Scholar
• Gu Y, Ma J, Liu Y, Chen B, Yao S. Determination of andrographolide in human plasma by high-performance liquid chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2007;854:328–31
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. Proniosomes: A novel drug carrier preparation. Int J Pharm, 2000;206:110–22
   PubMed Web of Science ®Google Scholar
• Jain CP, Vyas SP. Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul, 1995;12:401–7
   PubMed Web of Science ®Google Scholar
• Ji L, Liu T, Liu J, Chen Y, Wang Z. Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase. Planta Med, 2007;73:1397–401
   PubMed Web of Science ®Google Scholar
• Kim TG, Hwi KK, Hung CS. Morphological and biochemical changes of andrographolide-induced cell death in human prostatic adenocarcinoma PC-3 cells. In Vivo, 2005;19:551–7
   PubMed Web of Science ®Google Scholar
• Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci, 2001;90:667–80
   PubMed Web of Science ®Google Scholar
• Liang FP, Lin CH, Kuo CD, Chao HP, Fu SL. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway. J Biol Chem, 2008;283:5023–33
   PubMed Web of Science ®Google Scholar
• Maitani Y, Soeda H, Junping W, Takayama K. Modified ethanol injection method for liposomes containing beta-sitosterol beta-D-glucoside. J Liposome Res, 2001;11:115–25
   PubMed Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Murugan V, Saha BP, Mukherjee PK. Enhancing bioavailability and hepatoprotective activity of andrographolide from Andrographis paniculata, a well-known medicinal food, through its herbosome. J Sci Food Agric, 2010;90:43–51
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surfaces B: Biointerfaces, 2003;30:129–138
   Web of Science ®Google Scholar
• Muller D, Foulon M, Bonnemain B, Vandamme TF. Niosomes as carriers of radiopaque contrast agents for X-ray imaging. J Microencapsul, 2000;17:227–43
   PubMed Web of Science ®Google Scholar
• Nedelman JR, Gibiansky E, Lau DT. Applying Bailer's method for AUC confidence intervals to sparse sampling. Pharm Res, 1995;12:124–8
   PubMed Web of Science ®Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm, 2007;328:130–41
   PubMed Web of Science ®Google Scholar
• Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol, 1997;53:121–33
   PubMed Web of Science ®Google Scholar
• Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol, 2003;3:147–58
   PubMedGoogle Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: A controlled and novel drug delivery system. Biol Pharm Bull, 2011;34:945–53
   PubMed Web of Science ®Google Scholar
• Rao KY, Vimalamma G, Rao CV, Tzeng YM. Flavonoids and andrographolides from Andrographis paniculata. Phytochemistry, 2004;65:2317–21
   PubMed Web of Science ®Google Scholar
• Roy P, Das S, Bera T, Mondol S, Mukherjee A. Andrographolide nanoparticles in leishmaniasis: Characterization and in vitro evaluations. Int J Nanomed, 2010;5:1113–21
   PubMed Web of Science ®Google Scholar
• Sezgin Z, Yuksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm, 2006;64:261–8
   PubMed Web of Science ®Google Scholar
• Sheeja K, Kuttan G. Activation of cytotoxic T lymphocyte responses and attenuation of tumor growth in vivo by Andrographis paniculata extract and andrographolide. Immunopharmacol Immunotoxicol, 2007a;29:81–93
   PubMed Web of Science ®Google Scholar
• Sheeja K, Kuttan G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr Cancer Ther, 2007b;6:66–73
   PubMed Web of Science ®Google Scholar
• Shen KK, Liu TY, Xu C, Ji LL, Wang ZT. Andrographolide inhibits hepatoma cells growth and affects the expression of cell cycle related proteins. Yao Xue Xue Bao, 2009;44:973–9
   PubMedGoogle Scholar
• Shi MD, Lin HH, Lee YC, Chao JK, Lin RA, Chen JH. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact, 2008;174:201–10
   PubMed Web of Science ®Google Scholar
• Sinha J, Mukhopadhyay S, Das N, Basu MK. Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo. Drug Deliv, 2000;7:209–13
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm, 1998;172:33–70
   Web of Science ®Google Scholar
• Varshosaz J, Pardakhty A, Hajhashemi VI, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv, 2003;10:251–62
   PubMed Web of Science ®Google Scholar
• Vojdani A, Erde J. Regulatory T Cells, a potent immunoregulatory target for CAM researchers: Modulating allergic and infectious disease pathology (II). Evid Based Complement Alternat Med, 2006;3:209–15
   PubMedGoogle Scholar
• Zhao F, He EQ, Wang L, Liu K. Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level. J Asian Nat Prod Res, 2008;10:467–73
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang S, Ong CN, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol, 2006;72:132–44
   PubMed Web of Science ®Google Scholar